BRCA2 germline mutations in Swedish breast cancer families

被引:20
|
作者
Chen, JD
Hedman, MZ
Arver, BW
Sigurdsson, S
Eyfjörd, JE
Lindblom, A [1 ]
机构
[1] Karolinska Inst, S-17176 Stockholm, Sweden
[2] Iceland Canc Soc, Mol & Cell Biol Res Lab, Reykjavik, Iceland
关键词
hereditary breast cancer; breast cancer susceptibility gene; BRCA2; cancer family; gene mutation; familial breast cancer; mutations screening;
D O I
10.1038/sj.ejhg.5200167
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the breast cancer susceptibility gene (BRCA2) are believed to be responsible for a significant fraction of hereditary breast cancer. To determine the BRCA2 mutation spectrum in a subset of Swedish breast cancer families, 162 families were screened for germline mutations in this gene. A combination of RT-PCR, PTT and direct DNA sequencing was used. Two mutations and one previously reported polymorphic variant resulting in a truncated protein were identified. Our data suggest that only a small proportion of Swedish breast cancer families is attributable to BRCA2 germline mutations. This result, in combination with the low frequency of BRCA1 germline mutations identified in our previous study, suggests additional high penetrant as well as low penetrant breast cancer susceptibility genes are involved in familial breast cancer.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 50 条
  • [31] BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants
    Delgado, L.
    Fernandez, G.
    Grotiuz, G.
    Cataldi, S.
    Gonzalez, A.
    LLuveras, N.
    Heguaburu, M.
    Fresco, R.
    Lens, D.
    Sabini, G.
    Muse, I. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (01) : 211 - 218
  • [32] BRCA2 Germline Mutations in Cypriot Patients With Familial Breast/Ovarian Cancer
    Hadjisavvas, Andreas
    Charalambous, Elpida
    Adamou, Adamos
    Christodoulou, Christina G.
    Kyriacou, Kyriacos
    HUMAN MUTATION, 2003, 21 (02)
  • [33] BRCA2 Germline Mutations in Male Breast Cancer Patients in the Polish Population
    Kwiatkowska, Eliza
    Teresiak, Marek
    Lamperska, Katarzyna M.
    Karczewska, Aldona
    Breborowicz, Danuta
    Stawicka, Malgorzata
    Godlewski, Dariusz
    Krzyzosiak, Wlodzimierz J.
    Mackiewicz, Andrzej
    HUMAN MUTATION, 2001, 17 (01)
  • [35] Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer
    Henouda, Sarra
    Bensalem, Assia
    Reggad, Rym
    Serrar, Nedda
    Rouabah, Leila
    Pujol, Pascal
    DISEASE MARKERS, 2016, 2016
  • [36] Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients
    Verhoog, LC
    Berns, EMJJ
    Brekelmans, CTM
    Seynaeve, C
    Meijers-Heijboer, EJ
    Klijn, JGM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 119S - 124S
  • [37] Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient
    Randall, TC
    Bell, KA
    Rebane, BA
    Rubin, SC
    Boyd, J
    GYNECOLOGIC ONCOLOGY, 1998, 70 (03) : 432 - 434
  • [38] Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2
    Boyoung Park
    James G. Dowty
    Choonghyun Ahn
    Aung K. Win
    Sung-Won Kim
    Min Hyuk Lee
    Jong Won Lee
    Eunyoung Kang
    John L. Hopper
    Sue K. Park
    Breast Cancer Research and Treatment, 2015, 152 : 659 - 665
  • [39] A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
    Suman J. Ramus
    Lori S. Friedman
    Simon A. Gayther
    Bruce A.J. Ponder
    Lynda G. Bobrow
    Marco van der Looji
    Janos Papp
    Edith Olah
    Nature Genetics, 1997, 15 : 14 - 15
  • [40] Presence of germline BRCA2 mutations in sporadic breast cancer: Clinical correlation
    Gomendio, B
    Silva, JM
    Provencio, M
    GarciaPatino, E
    Garcia, JM
    SanMartin, S
    Rivera, T
    Cubedo, R
    Espana, P
    Bonilla, F
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 29 - 29